Clinical trial

Combination Chemotherapy With or Without Cetuximab Before and After Surgery in…

NCT00482222 · University of Southampton, Other · Unknown status

Key facts

NCT number NCT00482222
Title Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
Official title A Prospective Randomised Open Label Trial of Oxaliplatin/Fluoropyrimidine Versus Oxaliplatin/Fluoropyrimidine Plus Cetuximab Pre and Post Operatively in Patients With Resectable Colorectal Liver Metastasis Requiring Chemotherapy
Lead sponsor University of Southampton, Other
Collaborators University Hospital Southampton NHS Foundation Trust
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Colorectal Cancer, Metastatic Cancer
Intervention type Biological, Drug, Other, Procedure
Interventions cetuximab, capecitabine, fluorouracil, leucovorin calcium, oxaliplatin, study of socioeconomic and demographic variables, adjuvant therapy, neoadjuvant therapy, quality-of-life assessment
Enrollment 340
Start date Feb 1, 2007
Primary completion Dec 1, 2014
First posted Jun 5, 2007
Last update posted Jan 23, 2013
Countries United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • 1–9 FDA inspections linked to this trial
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies